STAAR Surgical files proxy, reiterates guidance

Ticker: STAA · Form: DEFA14A · Filed: Sep 2, 2025 · CIK: 718937

Staar Surgical Co DEFA14A Filing Summary
FieldDetail
CompanyStaar Surgical Co (STAA)
Form TypeDEFA14A
Filed DateSep 2, 2025
Risk Levellow
Pages8
Reading Time10 min
Key Dollar Amounts$28, $18.49
Sentimentneutral

Sentiment: neutral

Topics: proxy-filing, guidance, shareholder-communication

Related Tickers: STAA

TL;DR

STAAR Surgical filed a DEFA14A on 9/2/25, reiterating guidance. Bullish.

AI Summary

STAAR Surgical Company filed a DEFA14A on September 2, 2025, indicating it is soliciting materials under Rule 14a-12. The filing includes a press release issued on the same date, where STAAR Surgical reiterated its financial guidance.

Why It Matters

This filing signals that STAAR Surgical is actively communicating with shareholders regarding company matters and reaffirming its financial outlook, which can influence investor confidence and stock performance.

Risk Assessment

Risk Level: low — This is a routine proxy filing and press release reiterating guidance, with no immediate negative or significantly positive events indicated.

Key Players & Entities

  • STAAR Surgical Company (company) — Registrant
  • 0001193125-25-194146 (filing_id) — Accession Number
  • September 2, 2025 (date) — Filing Date and Press Release Date
  • Rule 14a-12 (regulation) — Soliciting Material

FAQ

What is the purpose of this DEFA14A filing?

The DEFA14A filing is for STAAR Surgical Company to solicit materials under Rule 14a-12, indicating it is providing information to shareholders, likely related to upcoming proxy votes or company communications.

When was this filing made and what key document was issued on that date?

The filing was made on September 2, 2025, and on the same date, STAAR Surgical Company issued a press release reiterating its financial guidance.

What type of materials is STAAR Surgical soliciting under Section 14(a) of the Exchange Act?

STAAR Surgical is soliciting materials under Rule 14a-12, which pertains to soliciting material under specific circumstances, as indicated by the checkmark in the filing.

What is the SIC code for STAAR Surgical Company?

The Standard Industrial Classification (SIC) code for STAAR Surgical Company is 3851, which corresponds to Ophthalmic Goods.

What is the fiscal year end for STAAR Surgical Company?

The fiscal year end for STAAR Surgical Company is December 27 (1227).

Filing Stats: 2,402 words · 10 min read · ~8 pages · Grade level 16.4 · Accepted 2025-09-02 17:22:49

Key Financial Figures

  • $28 — VWAP) as of that date. We believe the $28 per share cash value provided by the Al
  • $18.49 — Notably, STAAR's common stock closed at $18.49 per share on the trading day prior to t

Filing Documents

Forward-Looking Statements

Forward-Looking Statements The information covered by this communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "anticipate," "believe," "expect," "plan," "estimate," "project," "continue," "will," "should," "may," and similar terms. All statements in this communication that are not performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement between the parties to the proposed transaction or extend the anticipated timetable for completion of the proposed transaction; (2) the failure to obtain approval of the proposed transaction from STAAR's stockholders; (3) the failure to obtain certain required regulatory approvals or the failure to satisfy any of the other closing conditions to the completion of the proposed transaction within the expected timeframes or at all; (4) risks related to disruption of management's attention from STAAR's ongoing business operations due to the proposed transaction; (5) the effect of the announcement of the proposed transaction on the ability of STAAR to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business, or on its operating results and business generally; (6) the ability of STAAR to meet expectations regarding the timing and completion of the transaction; (7) the outcome of any legal proceedings that may be instituted against STAAR related to the proposed transaction; (8) the possib

Forward-looking statements speak only

Forward-looking statements speak only as of the date they are made and, except as may be required under applicable law, STAAR undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. CONTACT: Niko Liu, CFA United States: 626-303-7902 ext 3023 Hong Kong: +852-6092-5076 nliu@staar.com investorrelations@staar.com Connie Johnson +1 626 303 7902 (x-2207) cjohnson@staar.com 3 Additional Information About the Merger and Where to Find It This communication relates to the proposed transaction involving STAAR. In connection with the proposed transaction, STAAR has filed relevant materials with the U.S. Securities and Exchange Commission (the "SEC"), including STAAR's preliminary proxy statement on Schedule 14A, and will file a definitive proxy statement on Schedule 14A (the "Proxy Statement"). This communication is not a substitute for the Proxy Statement or any other document that STAAR may file with the SEC or send to its stockholders in connection with the proposed transaction. BEFORE MAKING ANY VOTING DECISION, STOCKHOLDERS OF STAAR ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC, INCLUDING THE PROXY STATEMENT, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS THERETO, IN CONNECTION WITH THE PROPOSED TRANSACTION WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain the documents (when available) free of charge at the SEC's website, www.sec.gov, or by visiting STAAR's investor relations website, https://investors.staar.com. No Offer or Solicitation This communication is for informational purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicita

Forward-Looking Statements

Forward-Looking Statements The information covered by this communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "anticipate," "believe," "expect," "plan," "estimate," "project," "continue," "will," "should," "may," and similar terms. All statements in this communication that are not performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement between the parties to the proposed transaction or extend the anticipated timetable for completion of the proposed transaction; (2) the failure to obtain approval of the proposed transaction from STAAR's stockholders; (3) the failure to obtain certain required regulatory approvals or the failure to satisfy any of the other closing conditions to the completion of the proposed transaction within the expected timeframes or at all; (4) risks related to disruption of management's attention from STAAR's ongoing business operations due to the proposed transaction; (5) the effect of the announcement of the proposed transaction on the ability of STAAR to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business, or on its operating results and business generally; (6) the ability of STAAR to meet expectations regarding the timing and completion of the transaction; (7) the outcome of any legal proceedings that may be instituted against STAAR related to the proposed transaction; (8) the possib

Forward-looking statements speak only

Forward-looking statements speak only as of the date they are made and, except as may be required under applicable law, STAAR undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. 4

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.